Category: Atypical Hemolytic Uremic Syndrome
January 16, 2024
Happy to share with you that our unit at Medanta is now part of International, Multicentric Phase 3 trial on Crovalimab in atypical hemolytic uremic syndrome in children and adults. There‚Äôs a need to explore more anti-complement drugs in aHUS. Kindly let us know if you have a patient of atypical HUS including post-partum HUS.